内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2021更新 NICE指南：成人1型糖尿病的诊断和管理（NG.17）

2021-07-21 英国国家卫生与临床优化研究所 NICE官网

糖尿病1型糖尿病

该指南涵盖了 1 型糖尿病成人（18 岁及以上）的护理和治疗。它包括关于诊断、教育和支持、血糖管理、心血管风险以及识别和管理长期并发症的建议。

中文标题：

2021更新 NICE指南：成人1型糖尿病的诊断和管理（NG.17）

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-07-21

简要介绍：

该指南涵盖了 1 型糖尿病成人（18 岁及以上）的护理和治疗。它包括关于诊断、教育和支持、血糖管理、心血管风险以及识别和管理长期并发症的建议。

2021年7 月，NICE审查了证据并更新了有关长效胰岛素治疗的建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 NICE指南：成人1型糖尿病的诊断和管理（NG.17）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8b8e01c0022622d8, title=2021更新 NICE指南：成人1型糖尿病的诊断和管理（NG.17）, enTitle=, guiderFrom=NICE官网, authorId=0, author=, summary=该指南涵盖了 1 型糖尿病成人（18 岁及以上）的护理和治疗。它包括关于诊断、教育和支持、血糖管理、心血管风险以及识别和管理长期并发症的建议。, cover=https://img.medsci.cn/20211114/1636857478374_1608702.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Wed Jul 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p class="lead" style="color: #0e0e0e;">该指南涵盖了 1 型糖尿病成人（18 岁及以上）的护理和治疗。它包括关于诊断、教育和支持、血糖管理、心血管风险以及识别和管理长期并发症的建议。</p> <p style="color: #0e0e0e;"><strong>2021</strong>年<strong>7 月</strong>，NICE审查了证据并更新了有关长效胰岛素治疗的建议。</p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=2054, tagName=1型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2054, guiderKeyword=1型糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=75645, appHits=281, showAppHits=0, pcHits=554, showPcHits=75363, likes=8, shares=30, comments=4, approvalStatus=1, publishedTime=Tue Nov 16 23:57:56 CST 2021, publishedTimeString=2021-07-21, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sun Nov 14 11:07:34 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 10:05:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE指南：成人1型糖尿病的诊断和管理（NG.17）.pdf)])
2021 NICE指南：成人1型糖尿病的诊断和管理（NG.17）.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2150458, encodeId=a1672150458ba, content=如何下载全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea8801679, createdName=ms8000000661364804, createdTime=Sun Jul 30 07:44:07 CST 2023, time=2023-07-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1195068, encodeId=59061195068a7, content=有木有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc136492037, createdName=ms2000000654684545, createdTime=Sat Feb 19 13:23:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191868, encodeId=40cb1191868c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf02947578, createdName=retsingya, createdTime=Thu Feb 10 16:05:31 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180378, encodeId=d7e211803e8a9, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=n7k8oktFPbwiaEstm2QaSwA&s=100&t=1554828773, createdBy=8ae05266295, createdName=yiwacaidi, createdTime=Tue Jan 04 13:21:07 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2023-07-30 ms8000000661364804 来自山东省

    如何下载全文

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2150458, encodeId=a1672150458ba, content=如何下载全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea8801679, createdName=ms8000000661364804, createdTime=Sun Jul 30 07:44:07 CST 2023, time=2023-07-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1195068, encodeId=59061195068a7, content=有木有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc136492037, createdName=ms2000000654684545, createdTime=Sat Feb 19 13:23:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191868, encodeId=40cb1191868c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf02947578, createdName=retsingya, createdTime=Thu Feb 10 16:05:31 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180378, encodeId=d7e211803e8a9, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=n7k8oktFPbwiaEstm2QaSwA&s=100&t=1554828773, createdBy=8ae05266295, createdName=yiwacaidi, createdTime=Tue Jan 04 13:21:07 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-02-19 ms2000000654684545

    有木有中文版的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2150458, encodeId=a1672150458ba, content=如何下载全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea8801679, createdName=ms8000000661364804, createdTime=Sun Jul 30 07:44:07 CST 2023, time=2023-07-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1195068, encodeId=59061195068a7, content=有木有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc136492037, createdName=ms2000000654684545, createdTime=Sat Feb 19 13:23:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191868, encodeId=40cb1191868c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf02947578, createdName=retsingya, createdTime=Thu Feb 10 16:05:31 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180378, encodeId=d7e211803e8a9, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=n7k8oktFPbwiaEstm2QaSwA&s=100&t=1554828773, createdBy=8ae05266295, createdName=yiwacaidi, createdTime=Tue Jan 04 13:21:07 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-02-10 retsingya

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2150458, encodeId=a1672150458ba, content=如何下载全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea8801679, createdName=ms8000000661364804, createdTime=Sun Jul 30 07:44:07 CST 2023, time=2023-07-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1195068, encodeId=59061195068a7, content=有木有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc136492037, createdName=ms2000000654684545, createdTime=Sat Feb 19 13:23:13 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191868, encodeId=40cb1191868c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cf02947578, createdName=retsingya, createdTime=Thu Feb 10 16:05:31 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180378, encodeId=d7e211803e8a9, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=n7k8oktFPbwiaEstm2QaSwA&s=100&t=1554828773, createdBy=8ae05266295, createdName=yiwacaidi, createdTime=Tue Jan 04 13:21:07 CST 2022, time=2022-01-04, status=1, ipAttribution=)]
    2022-01-04 yiwacaidi

    学习

    0

相关指南

成人2型糖尿病基础胰岛素起始调量期专家指导意见

中国内分泌相关专家小组（统称） · 2021-10-15

无症状糖尿病患者冠状动脉疾病的风险分层和筛查：法国心血管学会和法国糖尿病学会立场文件

法国心血管学会(FSC,French Society of Cardiology) · 2021-11-01

欧洲心脏病学会/心力衰竭协会关于新型降糖药物在心力衰竭患者中的作用和安全性的立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-11-04

糖尿病微循环障碍临床用药专家共识(2021年版)

中国微循环学会糖尿病与微循环专业委员会 · 2021-04-20

2021 JBDS-IP指南：糖尿病患者择期和急诊手术的围术期管理

英国糖尿病协会联合住院治疗组(JBDS-IP,Joint British Diabetes Societiesfor Inpatient Care Group) · 2021-03-10

2021 KDA临床实践指南：糖尿病

韩国糖尿病协会(KDA,Korean Diabetes Association) · 2021-07-15

拓展阅读

2015 JDRF/TES/ADA科学声明：1型糖尿病的前驱症状

美国糖尿病学会(ADA,American Diabetes Association) · 2015-09-20

2015 NICE指南：成人1型糖尿病的诊断和管理（NG.17）

暂未更新 · 2015-08-26

2017 共识声明：1型糖尿病的运动管理

国外内分泌相关专家小组（统称） · 2017-05-01

2018 ISPAD临床实践共识指南：儿童和青少年1型糖尿病的分期

国际儿童青少年糖尿病协会(ISPAD,International Society for Pediatric and Adolescent Diabetes) · 2018-07-26

2018 ADA立场声明：儿童和青少年1型糖尿病

美国糖尿病学会(ADA,American Diabetes Association) · 2018-08-09

2018 ISPAD临床实践指南：儿童和青少年囊性纤维化相关性糖尿病的管理

国际儿童青少年糖尿病协会(ISPAD,International Society for Pediatric and Adolescent Diabetes) · 2018-08-09